2 Coronary arteries were obtained from explanted hearts from patients undergoing cardiac transplantation (n=16 viable arteries from 13 males, 3 females, aged 38-68 years) and arterial segments (5-6 mm in length) were mounted in organ baths for isometric tension recording. Each segment was first exposed to 45m KCl and then to 5-HT ( 1 n-100 m). Concentrationeffect curves to rizatriptan and sumatriptan (Study 1, n=6 or 7 arteries) or sumatriptan and L-741,519 (Study 2, n=8 arteries) were then performed in a consecutive and random manner. The response to repeated application of 5-HT was obtained in separate segments. 3 One artery showed severe atheroma and was not included in the analysis.
ANOVA showed that 5-HT responsiveness varied significantly between arteries from different patients, but not between arterial segments from the same patient. Desensitization was seen consistently across all agonists but did not significantly affect inter-agonist comparisons. 4 There was graded effectiveness in the ability of the agonists to cause contraction with the rank order of E max values being 5-HTIsumatriptan>L-741,519>rizatriptan. In terms of EC 50 values, L-741,519 was significantly more potent than sumatriptan. 5 The present study (using a 'cross-over' experimental protocol) confirms our previous observation that rizatriptan is less effective than sumatriptan in causing contraction of human isolated coronary artery. Furthermore, it shows that the lower maximum contractile response to rizatriptan, compared with that of sumatriptan, is not merely the consequence of variability in response to 5-HT 1D -receptor agonists between patients or between segments from the same artery.
Keywords human coronary artery coronary vasoconstriction 5-HT 1D -receptor agonists
Introduction since heart transplant recipients were patients in the USA. Comparisons of the effects of L-741,519 with the effect of sumatriptan and 5-HT were also made. It is well established that human isolated coronary artery can both contract and relax in response to
The study was approved by the Ethics Committee, Baylor Medical College, Texas and a preliminary 5-hydroxytryptamine (5-HT) [ 1, 2 ]. Thus 5-HT can give rise to either coronary vasoconstriction or coronary communication of part of the study has been presented to the British Pharmacological Society [19 ] . vasodilation depending on the balance between these two opposing effects. In angiographic studies, 5-HT increased coronary artery diameter and blood flow in normal subjects but in patients with coronary artery disease, this response was lost and a vasoconstrictor Methods response was seen [3, 4 ] . These effects of 5-HT can be mediated via 5-HT 1D -or 5-HT 2 -receptor activation
In angiographic studies, intravenous administration Coronary arteries (left descending, left circumflex or right coronary arteries) were obtained from 19 patients of sumatriptan (a selective 5-HT 1D -receptor agonist) to patients caused a decrease in coronary artery diameter.
undergoing orthotopic cardiac transplant. Usable data were obtained from coronary artery rings of only 16 of However, this effect of sumatriptan was not accompanied by any clinical symptoms or changes in ECG [ 7] . Some these 19 patients; rings from the other three patients were not viable and these patients are not included in clinical trials involving the assessment of sumatriptan as an anti-migraine agent have reported that 'chestthe demographic summary. The average age (range) of these 16 patients was 55 years (38-68 years). Ten tightening' may be experienced by some subjects and coronary ischaemic episodes (including myocardial patients had ischaemic cardiomyopathy and the remaining six had dilated cardiomyopathy. There were 13 infarction and at least one death) have been reported [ 8, 9, 10, 11 ]. However, it should be noted that this males and three females in this group; two patients were African-American and 14 were Caucasian. Patients type of serious event is rare. Recently, it has been suggested that the relatively common 'chest-tightening' received a variety of medications prior to transplant. A majority (9/16) were receiving cardiac inotropic support symptoms may be related to oesophageal discomfort rather than to effects on the heart [12 ].
with either dobutamine or dopamine or both. Most patients were also being treated with angiotensin Rizatriptan (MK-462, (N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl ]ethylamine)) and its converting enzyme inhibitors (9/16) and many were also on diuretics (11/16) and nitrates (8/16). Some patients chemically related analogue L-741,519 (N-methyl-4-[5-( 1,2,4-triazol-4-yl)-1H-indol-3-yl] piperidine) are were receiving anti-arrhythmics (amiodarone, milrinone, vesnarinone). One patient was taking a serotonin novel 5-HT 1D -receptor agonists [ 13, 14, 15] . Rizatriptan has been effective in clinical trials to date as an reuptake inhibitor (fluoxetine). Except for one patient who received OKT3 (a monoclonal antibody for antimigraine agent [16] . In a previous study [ 17] , the effect of rizatriptan on human isolated coronary arteries immunosuppression) at the time of transplantation, all other patients were pre-treated just prior to transwas compared to those of sumatriptan and 5-HT; rizatriptan produced a smaller maximum contraction plantation with cyclosporine and azathioprine. Other medications taken by a minority of patients included than did 5-HT or sumatriptan. In this study [17 ] , one segment from each artery studied was exposed to a antibiotics, b 2 -adrenoceptor agonists, antiviral agents, histamine-receptor antagonists, oral hypoglycaemics, single agonist (either 5-HT, sumatriptan or rizatriptan). Recently, it has been reported that the contribution of anxiolytics and hypnotics, glucocorticoids, cholesterol lowering agents, anti-coagulants, lactulose, mannitol, 5-HT 1D -receptor activation to the contraction of human coronary artery shows considerable variation between aspirin, potassium chloride and magnesium oxide. segments taken from the same piece of artery, and can depend on the presence or absence of atheroma [5, 18 ] . It is therefore possible, that in the study by Ferro et al.
Preparation of arterial segments [ 17], differences in the responses to rizatriptan and sumatriptan may be explained, in part, by differences in Each artery was dissected from the heart immediately following explantation and was then kept at 4°C the responsiveness of individual artery segments.
The primary aim of the present study was to compare (0.5-7 h) in modified Kreb's physiological salt solution (composition in m: NaCl 118.3, KCl 4.7, MgSO 4 1.2, the effects of rizatriptan on human isolated coronary artery with those of 5-HT and sumatriptan using a KH 2 PO 4 1.2, NaHCO 3 25, glucose 11.1, CaCl 2 2.5; control solution) prior to commencing the experiment. cross-over experimental design to enable direct comparison of contractile effects on the same arterial segment,
The arteries were cleaned of connective tissue and the endothelium removed mechanically with the tip of thus eliminating any regional variation of 5-HT 1D -receptor responsiveness. In addition to using a different watchmaker's forceps. Each artery was cut into ring segments (each approximately 5-6 mm in length) with experimental design to that employed by Ferro et al.
[ 17], the present experiments also used a different between three to eight segments being obtained from each artery. Each segment was mounted for isometric patient population for the source of coronary arteries tension recording in tissue baths containing control segments assigned to Group 1, 5-HT was used as the agonist (Curves 2 and 3); for segments assigned to solution aerated with 95% O 2 and 5% CO 2 , maintained at pH 7.4 and temperature 37°C. The segments were Group 2 the order of application of the 5-HT 1D -receptor agonists was sumatriptan (Curve 2) followed stretched in a stepwise manner until they reached the maximum of the length-tension curve, which was by rizatriptan (Curve 3) and for segments assigned to Group 3, the order of agonist application was MK-462 determined by a comparable response to 45 m KCl at two different levels of stretch. The segments were (Curve 2 ) followed by sumatriptan (Curve 3 ). A similar cross-over design with respect to sumatriptan and then allowed to equilibrate to their own basal tension level.
L-741,519 was used in Study 2 (see Figure 1) . For each agonist, the response to each concentration was allowed to plateau (5-6 min) before addition of the next concentration. If no response was observed after 3 min, Experimental procedure the next concentration of the agonist was added to the organ bath. Further additions of agonists were For all segments from the same artery, contractions to 45 m KCl were first elicited and this response was suspended on attaining the maximum contractile response (i.e. where addition of a higher agonist used as a reference. To test for 5-HT responsiveness a cumulative concentration-effect curve to 5-HT was then concentration no longer produced a further increase in tension) or in cases, where no clear maximum response obtained in all segments (Curve 1 ). The segments were then randomly allocated to one of three groups (see could be defined, the maximum concentration of agonist added was 100 m. Following each concen- Figure 1 ) and subjected to two further consecutive agonist concentration-effect curves: in Study 1; for tration-effect curve the segments were washed several . Multiple segments were obtained from each coronary artery and randomly assigned to one of three groups. Each segment was then subjected to three agonist concentration-effect curves, with the agonists used being determined by Group-assignment: for both studies, all segments were subjected to an initial concentration-effect curve to 5-HT and then segments assigned to Group 1 were subjected to two further consecutive 5-HT concentration-effect curves; segments assigned to Groups 2 and 3 were also subjected to two further concentration-effect curves, with the order of application of sumatriptan and rizatriptan (Study 1) or sumatriptan and L-741,519 (Study 2) being reversed for Groups 2 and 3. The boxes indicate data sets which were pooled to obtain mean responses to each of the 5-HT receptor agonists. For example, in both Study 1 and Study 2 the mean sumatriptan response was obtained by pooling data in the second and third columns.
times in control solution until baseline tone was data were pooled and the overall mean data for each agonist were calculated. Concentration-effect curves re-established.
were then fitted to this overall mean data, using weighted least squares non-linear regression analysis and the same equation using BMDP statistical software Analysis of data (University of California Press, Los Angeles, USA). The weighting was the reciprocal of the error estimate for Comparison of overall effects of the agonists using analysis of variance (ANOVA) Responses to 5-HT, sumatriptan each mean value. Differences between the estimates E max and EC 50 values obtained for the agonists (i.e. derived and rizatriptan or L-741,519 were measured in g tension and expressed as a percentage of the response to 45 m from curve fitting to the overall mean data sets) were tested using asymptotic t-tests and error estimates from KCl. In some segments, contractile responses to the 5-HT 1D -receptor agonists were 'phasic' in nature (see the fitted results. Figure 2 ) and these contractions were measured in a similar way to 'tonic-type' contractions, with the response being measured as the maximum tension Results analyses were performed using BMDP statistical software (University of California Press, Los Angeles, Coronary arteries from 19 patients were studied, but arteries from three patients did not respond to 45 m USA) specialized for mixed and repeated measures designs, and which provide a method for testing KCl and were considered non-viable. Arteries from Patients 1 and 2 showed visible signs of minor nonlinear effects on repeated measures (agonist concentration). For the purpose of these ANOVAs a number atherosclerosis whilst the artery from Patient 3 showed major atherosclerosis and data from this vessel were of different dependent variables were used to describe aspects of the concentration-related response, including excluded from the statistical analyses. For most arterial segments, 5-HT and the 5-HT 1D -receptor agonists means, maximums, areas under the concentration-effect curve and a linearisation of the slope of this curve.
produced tonic (maintained ) contractions. Whereas in Study 1 some arterial segments showed a phasic Results were consistent no matter which measure was used and we report those for area under the curve and contraction (see Figure 2 for typical examples of tonic and phasic contractions to 5-HT), phasic contractions mean as appropriate.
were rarely seen in Study 2. For Study 1, statistical analysis (area under the concentration-effect curve) Comparison of concentration-effect curve parameters (E max and EC 50 values) using non-linear regression showed that contractions seen in segments which displayed 'tonic' activity were significantly greater in analysis All inter-agonist comparisons were made by pooling data obtained in Curves 2 and 3 (see Figure 1) . magnitude than contractions seen in segments which displayed 'phasic' activity (P<0.004). A coded variable Therefore for each artery (since multiple segments from each artery were used), mean responses to 5-HT were was used to represent this effect and to remove it from the dependent variables analysed. This analysis of calculated by pooling data obtained in Curves 2 and 3 for segments assigned to Group 1. In addition (due to covariance established that the nature of the contractile response (i.e. tonic or phasic) did not effect the outcome the cross-over design of the order of agonist application), mean responses to sumatriptan, rizatriptan or L-741,519 of the comparisons between the effects of the 5-HT receptor agonists. were calculated by pooling data obtained in Curves 2 and 3 across segments assigned to Groups 2 and 3 (see It was anticipated that patient medication at the time of heart transplantation would have little or no effect Figure 1 ). Then concentration-effect curves were fitted to the data using least squares non-linear regression on agonist evoked contractile responses, since few of the medications interact directly with 5-HT-receptors. analysis and the equation E=E max /(1+(EC 50 /agonist concentration)nH), where E max is the maximal contraction In addition, the arterial segments were washed several times in physiological buffer which is likely to remove evoked by each agonist (relative to 45 m KCl), EC 50 is the half maximally effective concentration and nH is any residual drugs. A preliminary statistical analysis was performed and no significant effects were seen the Hill coefficient, using Grafit Version 3.0 (Erithacus Software Ltd, Staines, UK). In addition, for all arteries although since each patient received a different cocktail of drugs the database was limited. tested in Study 1 and all arteries tested in Study 2, the sumatriptan, rizatriptan or L-741,519 for all segments from each artery are shown in Figures 3 and 4 There was a significant difference between the E max (means, using pooled data from Studies 1 and 2) showed 
values were obtained from concentration-effect curves fitted to data obtained from multiple segments from the same artery (Curves 2 and 3). For some segments, no clear maximum response was observed and it was not possible to calculate E max or EC 50 values using non-linear regression analysis, therefore for these segments * denotes the size of the contractile response observed at the highest concentration of agonist tested (100 m). In addition, estimates were made for the overall E max and EC 50 values by fitting concentration-effect curves to the overall mean data obtained in Study 1 and Study 2 and the values shown represent mean and asymptotic s.e. 'n' refers to the number of individual arteries tested. NT=not tested In human isolated coronary artery, contractile responses to 5-HT were similar in magnitude to contractions respectively).
Patient number
evoked by 45 m KCl and all viable arteries responded to 5-HT. Statistical analysis showed variability in 5-HT responsiveness between arteries obtained from different patients and furthermore, the variability between segDiscussion ments from the same artery differed significantly from patient to patient. In addition there was a significant In the present experiments, a modified cross-over design (with respect to the order of application rizatriptan and difference in 5-HT responsiveness between the two studies, where the magnitude of the contractions was sumatriptan or L-741,519 and sumatriptan to individual arterial strips) was employed to compare directly the greater in Study 2 than Study 1. This probably reflects the smaller magnitude of phasic contractile responses effects of rizatriptan and sumatriptan or L-741,519 and sumatriptan on the same segment of human isolated which were often seen in Study 1 but not in Study 2. Variability of 5-HT responsiveness of human coronary coronary artery. Statistical comparisons showed there was significant desensitization to the agonists throughartery is well documented but the underlying reason is not clear. 5-HT responsiveness may be influenced by out the course of the experiment, however, there was no evidence of interaction between this and the measured disease state and in particular atheroma [5, 20] 
Comparison of the effects of 5-HT 1D
-receptor agonists
Comparison of the overall EC 50 values showed rizatriptan and sumatriptan were similarly potent in causing contraction of human isolated coronary artery, whereas L-741,519 was approximately 10-fold more potent. This observation is consistent with the relative affinities of these compounds for 5-HT 1D -receptors measured in radioligand binding studies [13] [14] [15] and with the relative potencies in causing contraction of rabbit isolated saphenous vein (a 5-HT 1D -receptor bioassay [15, 22, 23] ).
Comparison of the overall E max values showed a graded efficacy in the ability of 5-HT 1D -receptor agonists to contract human isolated coronary artery, with L-741,519 being less effective than sumatriptan and and rizatriptan were made on the same arterial segments data collected for each agonist in Curves 2 and 3. Vertical (using a cross-over design) whereas in the study by bars signify ±s.e. mean. Curves were fitted to overall mean Ferro et al.
[ 17] each arterial segment was exposed to data using weighted least squares non-linear regression a single agonist (sumatriptan or rizatriptan).
analysis.
The reason why rizatriptan should be less efficacious than other compounds of the same structural class is as yet not known. In vitro functional assays using rabbit with atherosclerotic lesions or in patients with angina, 5-HT causes coronary vasoconstriction [3, 4 ] As already discussed by Ferro et al. Yet the overall conclusions were the same as those of
